Diagnostics, prevention and therapy of lower vena cava system thrombosis
Abstract
Vein thrombosis in the lower vena cava system is a frequent pathology and makes up to 90-95% of venous thromboses. The venous system thromboses should be viewed as a potential danger of the pulmonary artery thromboembolia development with grave consequences [1]
About the Authors
M. D. Dibirov
Evdokimov Moscow State Medical and Stomatologic University
Russian Federation
Russian Federation
A. H. Magdiev
Evdokimov Moscow State Medical and Stomatologic University
Russian Federation
Russian Federation
References
1. Сосудистая хирургия. Национальное руководство. Краткое издание под ред. В.С. Савельева и А.И. Кириенко. Гэотар-Медиа, 2014: 316-363.
2. NicoLaides AN et aL. Тромбофилия и венозный тромбоэмболизм. Руководство и научные обоснования под покровительством Европейского общества генетиков, сердечно-сосудистого образовательного и исследовательского траста, Международного общества ан-гиологов и Средиземноморской лиги тромбоэмболизма. Medline, 2003.
3. TogLia MR, Weg JG. Venous thromboembolism during pregnancy. N Engl J Med, 1996, 335: 108-14.
4. BorreLL M, Antonijoan RM, Ortin R et aL. Pharmacokinetic profiles of two LMWH: Bemiparin 3,500 IU and Enoxaparin 4,000 IU after subcutaneous administration in healthy volunteers. Thromb. Haemost., 2001, 86(SuppL.): CD3578.
5. Российские клинические рекомендации по диагностике, лечению и профилактике венозных тромбоэмболических осложнений. Ассоциация флебологов России, Всероссийское общество хирургов. М.: Медиа Сфера, 2010.
6. Geerts WH, Bergqvist D, Pineo GF et aL. Prevention of Venous Thromboembolism. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest, 2008, 133: 381-453.
7. FaLkon L, Saenz-Campos D, Antonijoan R, Martin S, Barbanoj M, Fontcuberta J. Bioavailability and pharmacokinetics of a new low molecular weight heparin (RO-11). A three way cross-over study in healthy volunteers. Thromb. Res., 1995, 78: 77-86.
8. Planes A. Review of bemiparin sodium -- a new second-generation low molecular weight heparin and its applications in venous thromboembolism. Expert Opin Pharmacother, 2003, 4 (9): 1551-61.
9. Инструкция по медицинскому применению препарата Цибор® 2500 http://www.rLsnet.ru/tn_index_id_42309.htm.
Review
For citations:
Dibirov M.D., Magdiev A.H. Diagnostics, prevention and therapy of lower vena cava system thrombosis. Ambulatornaya khirurgiya = Ambulatory Surgery (Russia). 2016;(3-4):69-76. (In Russ.)
Views:
1024
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International.
Email this article 